Search

Your search keyword '"Gisella Cavallo"' showing total 99 results

Search Constraints

Start Over You searched for: Author "Gisella Cavallo" Remove constraint Author: "Gisella Cavallo" Topic medicine Remove constraint Topic: medicine
99 results on '"Gisella Cavallo"'

Search Results

1. Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity

2. Overview of studies of the vitamin D/vitamin D receptor system in the development of non-alcoholic fatty liver disease

3. The single-point insulin sensitivity estimator (SPISE) index is a strong predictor of abnormal glucose metabolism in overweight/obese children: a long-term follow-up study

4. Biliverdin reductase-A protein levels are reduced in type 2 diabetes and are associated with poor glycometabolic control

5. The rs45454496 (E1813K) variant in the adiposity gene ANK2 doesn't associate with obesity in Southern European subjects

6. Expression of TGR5 in adipose tissue in relation to metabolic impairment and adipose tissue dysfunction in human obesity

7. High pro-neurotensin levels in individuals with type 1 diabetes associate with the development of cardiovascular risk factors at follow-up

8. Hypovitaminosis D is independently associated with metabolic syndrome in obese patients.

9. Reduced Biliverdin Reductase-A Expression in Visceral Adipose Tissue is Associated with Adipocyte Dysfunction and NAFLD in Human Obesity

10. Granzyme B in Inflammatory Diseases: Apoptosis, Inflammation, Extracellular Matrix Remodeling, Epithelial-to-Mesenchymal Transition and Fibrosis

11. Vitamin D and Metabolic Dysfunction-Associated Fatty Liver Disease (MAFLD): An Update

12. Circulating pro-neurotensin levels predict bodyweight gain and metabolic alterations in children

13. 570-P: Osteoprotegerin Induces Endothelial Dysfunction and Is Associated with Vascular Complications In Type 2 Diabetes

14. COVID-19 and diabetes: Is this association driven by the DPP4 receptor? Potential clinical and therapeutic implications

15. Association of apelin levels in overweight-obese children with pubertal development, but not with insulin sensitivity: 6.5 years follow up evaluation

16. Angiopoietin-like protein 4 overexpression in visceral adipose tissue from obese subjects with impaired glucose metabolism and relationship with lipoprotein lipase

17. Adipose tissue remodelling in obese subjects is a determinant of presence and severity of fatty liver disease

18. Granzyme B Expression in Visceral Adipose Tissue Associates With Local Inflammation and Glyco-Metabolic Alterations in Obesity

19. Relationship between hepatic and systemic angiopoietin-like 3, hepatic Vitamin D receptor expression and NAFLD in obesity

20. Altered glucose homeostasis is associated with increased serum apelin levels in type 2 diabetes mellitus.

21. ANGPTL4 gene E40K variation protects against obesity-associated dyslipidemia in participants with obesity

22. Presence of diabetes-specific autoimmunity in women with gestational diabetes mellitus (GDM) predicts impaired glucose regulation at follow-up

23. The vitamin D receptor functional variant rs2228570 (C>T) does not associate with type 2 diabetes mellitus

24. Effect of vitamin D supplementation on markers of vascular function: a systematic review and individual participant meta‐analysis

25. Elevated plasma copeptin levels identify the presence and severity of non-alcoholic fatty liver disease in obesity

26. Sick fat: the good and the bad of old and new circulating markers of adipose tissue inflammation

27. Reduced biliverdin reductase-A levels are associated with early alterations of insulin signaling in obesity

28. Circulating miRNA-375 levels are increased in autoantibodies-positive first-degree relatives of type 1 diabetes patients

29. Greater circulating DPP4 activity is associated with impaired flow-mediated dilatation in adults with type 2 diabetes mellitus

30. Impaired bone matrix glycoprotein pattern is associated with increased cardiometabolic risk profile in patients with type 2 diabetes mellitus

31. Technological support to intensive insulin therapy by a novel smartphone application in young adults with type 1 diabetes: one center's experience

32. Phenotypical heterogeneity linked to adipose tissue dysfunction in patients with Type 2 diabetes

33. Dipeptidyl peptidase-4 inhibitors and bone metabolism: is vitamin D the link?

34. The vitamin D receptor (VDR) gene rs11568820 variant is associated with type 2 diabetes and impaired insulin secretion in Italian adult subjects, and associates with increased cardio-metabolic risk in children

35. Effects of work status changes and perceived stress on glycaemic control in individuals with type 1 diabetes during COVID-19 lockdown in Italy

36. Increased circulating granzyme B in type 2 diabetes patients with low-grade systemic inflammation

37. Neurotensin Is a Lipid-Induced Gastrointestinal Peptide Associated with Visceral Adipose Tissue Inflammation in Obesity

38. Association between systemic leptin and neurotensin concentration in adult individuals with and without type 2 diabetes mellitus

39. Procollagen-III peptide identifies adipose tissue-associated inflammation in type 2 diabetes with or without nonalcoholic liver disease

40. Increased Plasma Proneurotensin Levels Identify NAFLD in Adults With and Without Type 2 Diabetes

41. Comment on Elangovan H et al. vitamin D in liver disease: Current evidence and potential directions. Biochim Biophys Acta 2017;1863(4):907-916

42. Vitamin d supplementation and non-alcoholic fatty liver disease: Present and future

43. Circulating IL-8 levels are increased in patients with type 2 diabetes and associated with worse inflammatory and cardiometabolic profile

44. Relationship between adipose tissue dysfunction, Vitamin D deficiency and the pathogenesis of non-alcoholic fatty liver disease

45. WISP1 Is a Marker of Systemic and Adipose Tissue Inflammation in Dysmetabolic Subjects With or Without Type 2 Diabetes

46. The Arg282Ser missense mutation in APOA5 gene determines a reduction of triglyceride and LDL-cholesterol in children, together with low serum levels of apolipoprotein A-V

47. THU-296-Hepatic and visceral adipose tissue expression of vitamin D receptor and vitamin D hydroxylases in relation to non-alcoholic fatty liver disease and adipose tissue inflammation

48. No effects of oral vitamin D supplementation on non-alcoholic fatty liver disease in patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial

49. Search for Genetic Variant in the Apelin (APLN) Gene by Resequencing and Association Study in European Subjects

50. Increased circulating osteopontin levels in adult patients with type 1 diabetes mellitus and association with dysmetabolic profile

Catalog

Books, media, physical & digital resources